Guo, H., Ding, P., Yang, P., Tian, Y., Liu, Y., Zhang, Z., Zheng, T., Wang, D., Zhang, Z., Zhao, Q. (2026). HIPEC combined with NIPS and tislelizumab for conversion therapy in gastric cancer with peritoneal metastasis (P0CY1 or PCI ≤10): A prospective, single-arm, phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps4240